Allylestrenol Impurities

Allylestrenol is a progestational steroid that is synthetic.

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Allylestrenol Allylestrenol Impurity A VL5860002View CAS 3646-28-4
Allylestrenol Allylestrenol Impurity B VL5860003View

Allylestrenol Related Compound

It increases the hormonal effects of pre-existing syncytiotrophoblast, which are required for progesterone synthesis. a medicine used to treat recurrent and threatening miscarriage and to prevent preterm labor.

References

  • Malhotra, Narendra, et al. “Oral Allylestrenol: A Pregnancy-Supporting Progestogen.” Journal of SAFOG with DVD, edited by Jaideep Malhotra, vol. 9, no. 4, 2017, pp. 297–303, https://doi.org/10.5005/jp-journals-10006-1517. Accessed 19 Feb. 2019.
  • PubChem. “Allylestrenol.” @Pubchem, PubChem, 2023, pubchem.ncbi.nlm.nih.gov/compound/Allylestrenol#:~:text=Allylestrenol%20%7C%20C21H32O%20%7C%20CID%20235905%20%2D%20PubChem. Accessed 2 July 2023.

FAQ

What is the drug Allylestrenol used for?

Allylestrenol is a steroid that is used to prevent pregnant women from progressing into preterm labor.it is a progestational steroid that is synthetic.

What is the therapeutic class of Allylestrenol?

Allylestrenol is an estrogen-derivative progestogen that is utilized in progestogenic hormone formulations.

What is the function of Allylestrenol during pregnancy?

Allylestrenol is a biosynthetic progestogen that has been used in the treatment of mild to severe obstetric problems such as miscarriage/abortion, threatening preterm labor, intrauterine growth restriction (IUGR), and gestational hypertension.

[rfq_list]

Request a quote

3646-28-4: Allylestrenol Impurity A

3646-28-4: Allylestrenol Impurity A
Catalogue No.

VL5860002

CAS No.

3646-28-4

Molecular Formula

C18H26O

Molecular Weight

258.41

Parent drug

Allylestrenol

IUPAC Name

(8R, 9S, 10R, 13S, 14S)-13-methyl-2, 3, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16-dodecahydro-1H-cyclopenta[a]phenanthren-17(6H)-one

Synonyms

N/A

References

Shi, Xiaopeng, et al. “Application of a Sensitive Liquid Chromatographic/Tandem Mass Spectrometric Method to a Pharmacokinetic Study of Allylestrenol in Healthy Chinese Female Volunteers.” Journal of Chromatography B, vol. 871, no. 1, Aug. 2008, pp. 90–94, https://doi.org/10.1016/j.jchromb.2008.06.054. Borglin, N. E., and G. Eliasson. “Analysis of the Pregnancy-Maintaining Effect of Allylestrenol in Threatened and Habitual Abortion.” Fertility and Sterility, vol. 13, no. 5, Sept. 1962, pp. 411–2

Status

Under Development

ListName

Allylestrenol Impurity A

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden